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Structured Abstract 
Background: The Medicare National Coverage Determination for cardiac pacemakers 
(PM), which emphasized single chamber pacing, has not significantly changed since 
1985.  We sought to define contemporary trends in PM utilization by analyzing a large 
national database. 
Methods: We queried the Nationwide Inpatient Sample (NIS) to identify PM implants 
between 1993-2009 using the ICD-9-CM procedure codes for dual chamber (DDD) PM, 
single ventricular (VVI) PM , single atrial (AAI) PM or bi-ventricular (BiV) PM.  Annual 
PM implantation rates and patient demographics were analyzed over time.  
Results: Between 1993-2009, 2.9 million patients received PM in the U.S.  Overall 
utilization increased by 55.6%.  By 2009, DDD increased from 62% to 82% (p<0.001) 
while VVI fell from 36 to 14% (p=0.01). Utilization of DDD was higher in urban, 
nonteaching (79%) as compared to urban, teaching (76%) and rural hospitals (72%). 
Patients with private insurance (83%) more commonly received DDD than Medicaid 
(79%) or Medicare (75%) pts (p<0.001).  Age of PM patients increased over time for 
both DDD and VVI (p<0.001). VVI were older than DDD patients.  Charlson Co-
morbidity Index (CCI) increased over time. By 2009, 45% VVI and 42% DDD had 
CCI>2.  Hospital charges ($2011) increased 45.3% driven by the increased cost of DDD. 
Conclusions: There is a steady growth in the utilization of PM in the U.S.  DDD PM are 
increasing while VVI PM are decreasing.  PM patients are getting older with more 
medical co-morbidities. These trends have important implications for health care policy. 
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Abbreviations: 
PM= Permanent pacemaker 
DDD= Dual chamber pacemaker 
VVI= Single chamber ventricular pacemaker 
AAI= Single chamber atrial pacemaker 
BiV= Bi-ventricular pacemaker 
NCD= National Coverage Determination  
4 
 
Implantation of cardiac pacemakers in the United States has increased.1-4  This is likely 
due to an aging population along with improvements in the treatment of heart disease.  
Pacemaker technology has advanced from fixed-rate single chamber pacemakers to dual 
chamber pacemakers with pacing algorithms to enhance rate response and minimize 
ventricular pacing.  Despite these advancements, the National Coverage Determination 
(NCD) for Cardiac Pacemakers, published by the Centers for Medicare and Medicaid 
Services (CMS), has not significantly changed since 1985.5  We evaluated the trends in 
cardiac pacemaker implantation in the United States to evaluate the disparity between the 
policies outlined in the NCD, which emphasized the role of single chamber pacing, and 
contemporary medical practice.    
 
Methods 
The Nationwide Inpatient Sample (NIS) was queried to identify patient demographics 
(e.g. age, sex), health risk profile/risk (incidence and severity of co-morbidities), and 
health economic (in-hospital charges) data for pacemaker patients between 1993 and 
2009 using the International Classification of Diseases-9th Revision-Clinical Modification 
(ICD-9-CM).  The annual NIS is a statistically valid annual survey of ~20% of 
hospitalizations in the U.S. regardless of payment source.  For each patient, the type of 
pacemaker implanted was characterized as either a dual chamber (DDD), single chamber 
ventricular (VVI), single chamber atrial (AAI), or bi-ventricular (BiV) pacemaker.  For 
the present study, we identified pacemaker implants by the ICD-9 codes for DDD (37.83), 
VVI (37.81-82+37.71), AAI (37.81-81+37.73), or BiV (00.51).  Trends were also 
analyzed for the subgroup of patients with sinus node dysfunction using diagnosis codes 
427.8 and 427.6.   
The type of device implanted (DDD vs. VVI vs. AAI vs. BiV) was analyzed along with 
the patient health profile using coding for such items as renal failure, heart failure, 
respiratory failure, and diabetes mellitus.  The severity of co-morbidities was 
characterized by the Charlson Comorbidity index which consists of 19 different disease 
co-morbidity categories, weighted yield a total score.6  The CCI has previously been 
validated as a predictor of mortality in patients with a pacemaker.4 
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Statistical analyses of the NIS records with the relevant surgical codes were conducted 
using SAS (version 9.2, Cary, North Carolina).  Hospital charges over the time period of 
this study were adjusted to the equivalent amount in January 2011 using the consumer 
price index for medical services published by the Bureau of Labor Statistics. The 
sampling weights and the stratified sampling design of the NIS were taken into 
consideration when computing summary statistics and standard errors of these estimates. 
The number of surgeries performed for a particular demographic group is a positive 
integer and is assumed to follow a Poisson distribution. A regression model was used to 
estimate the surgery rate, and was normalized by the size of the population, and 
evaluation of the calendar year trend. The surgery rate was adjusted by age, sex, race, and 
census regions to accommodate differences in the prevalence among demographic 
subpopulations. The patient health profile was calculated for each year and linear 
regression was used to test for changes over time.  The type of hospital performing 
pacemaker surgery was divided into one of three groups:  urban non-teaching, urban 
teaching, and rural.   The distribution of pacemaker surgery was also analyzed for the 
three types of hospitals as well as the type of insurance (private vs. Medicaid vs. 
Medicare).    
 
RESULTS 
 
Between 1993 and 2009, 2.9 million patients received a permanent pacemaker in the 
United States.  During this time period, overall utilization increased by 55.6%, from 
121,300 in 1993 to 188,700 in 2009.    This represents 46.7 implantations/100,000 
persons in 1993, which increased to 61.6 implantations/100,000 persons in 2009 [Figure 
1].  DDD pacemakers increased annually from 29.1/100,000 to 50.4/100,000 (p<0.0001) 
while, at the same time, VVI pacemakers decreased from 17.2/100,000 to 8.7/100,000 
(p=0.01).  By 2009, DDD increased from 62% to 82% of all implants (p< 0.001) while 
VVI decreased from 36% to 14% (p=0.01).  AAI remained constant at 1% while BiV 
pacemakers increased to 4% in 2009 from a base in 2001.  
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Demographic trends 
The impact of gender on pacemaker utilization was analyzed.  During the study period, 
DDD pacemakers were implanted in 77.3 % of men, while 20.1 % received VVI, 0.5 % 
AAI and 1.9 % BiV pacemakers.  By contrast, 76.8 % of women received DDD 
pacemakers, while 21 % received VVI, 0.6 % AAI, and 0.6 % received BiV pacemakers.   
The mean age of pacemaker patients at the time of implantation increased over time.  
[Figure 2]  In addition, patients receiving a VVI pacemaker were older than those with a 
DDD pacemaker (p<0.0001).  In 1993, those receiving DDD pacemakers averaged 73.3 
years which increased to 75.4 years in 2009 (p<0.0001).  By contrast, in 1993 those 
receiving a VVI pacemaker were 77.5 years which increased to 80.1 in 2009 (p<0.0001).  
Those receiving a BiV pacemaker also increased in age from 71.8 in 2002 to 74.7 years 
in 2009 (p<0.0001).   
 
Trends Based on Type of Hospital and Insurance 
The influence of hospital location was analyzed by evaluating pacemaker utilization in 
rural hospitals, urban non-teaching hospitals, and urban teaching hospitals.  Utilization of 
DDD pacemakers was higher in urban non-teaching hospitals (79%) as compared to 
urban teaching (76%), and rural hospitals (73%) which was significant (p<0.01). Patients 
with private insurance (83%) more commonly received DDD than Medicaid (79%) or 
Medicare (75%) patients (p<0.001).  To further analyze the impact of insurance type, the 
utilization of DDD pacemakers was evaluated after adjusting for factors such as age, sex, 
race, calendar year, urban/rural, and hospital size.  After controlling for these factors, 
Medicaid patients were less likely than Medicare patients (HR 0.84, C.I. 0.79-0.886, 
p<0.001) whereas private insurance patients were more likely than Medicare patients (HR 
1.205, C.I. 1.165-1.247, p<0.001) to receive DDD pacemakers. 
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Trends in Patient Co-morbid Conditions 
Patient co-morbidities were analyzed by measuring the average Charlson Co-morbidity 
Index for each calendar year.  The patient level of co-morbidity increased over time for 
all types of pacemakers.  Co-morbidities were analyzed for each type of pacemaker.  In 
1993, the average CCI was 0.6±0.9 for patients with a dual chamber pacemaker vs. 0.6±1 
for patients with a single chamber VVI pacemaker.  By contrast, in 2009 dual chamber 
pacemaker patients had a CCI of 1.5±1.5 and single chamber VVI patients had a CCI of 
1.6±1.6. The complexity of the patient’s condition was measured by determining the 
number of patients with a CCI of greater than 2.  In 1993, a CCI of greater than was 2 
present in 14.1% of VVI patients which increased to 45.1% in 2009.  A similar trend was 
seen in the group of patients receiving a DDD pacemaker.  In 1993, 13.5% of patients 
had a CCI greater than 2 which increased to 42.4% in 2009.   
 
Pacemaker Implantation Trends in Patients with Sinus Node Dysfunction 
In order to evaluate the impact of the diagnosis of sick sinus dysfunction on device 
utilization, we analyzed PM implants in this subgroup by using codes 427.81 (sick sinus 
syndrome) and 426.6 (sinoatrial block).  (Figure 3)  Utilization of DDD PM increased 
while VVI PM decreased.  By 2009, over 80% of patients with sinus node dysfunction 
received a DDD PM while 1.4% of these patients received a BiV pacemaker.  Therefore, 
the diagnosis of sinus node dysfunction did not appear to have an impact on the type of 
device implanted. 
 
Economic Trends in PM Implantation 
We queried the NIS to determine hospital charges associated with pacemaker insertion 
between the years 1993 and 2009 as an indicator of economic cost.  Total hospital 
charges associated with pacemaker procedures increased during the study period.  (Figure 
4)   Hospital charges in $2011 increased by 45.3% from $53,693 in 1993 to $78,015 in 
2009.  
 
 
8 
 
DISCUSSSION 
The major findings of this analysis of a large national database are: (1) there has been a 
growth in permanent pacemaker implantations in the United States, (2) there has been a 
plateau in the yearly rate of pacemaker implantation since 2001, (3) utilization of dual 
chamber pacemakers increased whereas single chamber VVI pacemakers decreased.  
DDD pacemakers now represent more than 80% of  all pacemaker implants, (4)  
pacemaker patients are getting older and have a greater number of medical co-morbidities, 
(5)  the utilization of dual chamber pacemakers was impacted by the type of hospital and 
type of health insurance, (6) these trends have financial implications as hospital charges 
increased.   
 
Trends in Permanent Pacemaker Implantation 
We found that although there has been an overall increase in the annual pacemaker 
implantation rate (number of implants/100,000 persons) since 1993, the rate has remained 
fairly constant since 2001.  The 2005 World Survey of Cardiac Pacing confirmed this 
trend as new implants in the U.S. were 786 per million in 2001 and 752 per million in 
2005.2  Our previous study showed that overall pacemaker implantation peaked in 2001, 
while the overall utilization of cardiac implantable electronic devices (CIED) continued 
to increase through 2006, driven by the marked increase in ICD implantation and 
introduction of cardiac resynchronization therapy.1 
 
 
Utilization of Dual Chamber Pacemakers 
Dual chamber technology has been adopted as the technology of choice in the United 
States.  This technology represents an advance over single chamber ventricular demand 
pacemakers.  Current dual chamber pacemakers have the capability to provide 
bradycardia support at the lower rate limit while maintaining AV synchrony, as well as 
rate responsiveness at faster heart rates by tracking the intrinsic P wave.  At the same 
time, current pacemaker algorithms minimize ventricular pacing by allowing intrinsic AV 
conduction.7,8  In our study, the rate of utilization of dual chamber pacing was similar for 
all patients, regardless of the indication for pacing. 
9 
 
The shift in utilization to dual chamber technology likely reflects the improvements in 
lead and pacemaker design, that simplify implantation, as well as the results of clinical 
trials which highlighted the clinical benefits of atrial- based pacing.  Five major clinical 
trials compared atrial- based pacing to ventricular-based pacing.9-13   These trials are more 
commonly known as the Danish trial, PASE, MOST, CTOPP, and UKPACE.  Results 
from these clinical trials consistently demonstrate that atrial- based pacing prevents 
pacemaker syndrome, reduces the incidence of atrial fibrillation, decreases the incidence 
of congestive heart failure, and improves quality of life.  A meta-analysis of the results of 
eight pacing trials also demonstrated a modest reduction in stroke14 while the Danish trial 
showed a decrease in mortality.15  Following publication of these trials, the 
ACC/AHA/HRS 2008 guidelines for device based therapy of cardiac rhythm 
abnormalities recommended dual chamber pacing for the treatment of symptomatic 
bradycardia in patients who were in sinus rhythm and in whom AV synchrony and rate 
responsiveness were desirable.16  This represents most patients referred for cardiac pacing.  
It is possible that the timing of the shift towards dual chamber technology that we 
observed may have been a response to these clinical trials.  Our study confirms that the 
NCD for pacing, which emphasized single chamber pacing and was last modified in 1985, 
is not in line with contemporary clinical practice. 
 
Demographics of Pacemaker Patients 
Pacemaker patients are generally elderly with associated medical co-morbidities.  Our 
study confirms that pacemakers are being implanted later in life in patients with a greater 
number of medical co-morbidities.  These findings are consistent with the 30 year study 
of pacemaker recipients in Olmstead County, Minn.4   In that study, the age adjusted 
Charlson index increased from 3.15 to 4.60 over the study period (p<0.0001).  Increasing 
Charlson index had an adverse effect on prognosis following pacemaker implantation.  
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Implantation Trends:  Influence of Health Insurance and Hospital Type 
Pacemaker selection is likely influenced by factors other than the patient’s age or 
associated medical conditions.  Lamas and co-workers analyzed a cohort of pacemaker 
recipients sampled from 20% of all Medicare beneficiaries over a 2-year period.17  They 
found that patients referred to large, urban, teaching hospitals were more likely to receive 
dual chamber pacemakers.  In addition, Medicaid patients were less likely to receive a 
dual chamber pacemaker (OR, 0.78, CI, 0.71 to 0.86).  We found that both type of 
insurance and implanting hospital impact pacemaker selection.  Previous investigators 
have raised the possibility that economically disadvantaged patients may have less access 
to more advanced technology.4,17  The reasons for these disparities cannot be readily 
explained by our study. 
 
Financial Implications of Pacemaker Utilization 
Finally, we observed that hospital charges are increasing despite a decrease in the length 
of stay.   Improvements in technology, often associated with dual chamber pacing, come 
at a higher cost.  It is unclear whether these costs will continue to rise and to what extent 
the healthcare system can withstand this financial burden.     
 
Limitations 
The present analysis utilized the NIS which is a national survey of hospital discharges.  
This survey thus underestimates the total pacemaker implantation rate since it does not 
capture outpatient procedures.  In addition, the NIS suffers from the inherent limitations 
of administrative data, namely the absence of clinical data.  Nonetheless, it is a large 
database representing national trends in hospitalized patients. 
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Conclusions 
In summary, pacemaker implantation in the United States has increased over a 17 year 
period.  Patients are older and have more medical co-morbidities.  The vast majority of 
pacemakers are dual chamber pacemakers, regardless of the indication for pacing.   There 
are disparities in the utilization of dual chamber pacing, which may be based, in part, on 
the type of hospital and insurance.  The costs associated with pacemaker implantation are 
rising as well.  These findings have important implications for future healthcare policy 
decisions. 
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FIGURE 1:  Pacemaker Utilization in the United States from 1993 to 2009:  The rate of 
dual chamber pacemaker implantation (number of implants/100,000 persons)  has 
increased over time until 2001 when utilization reached a plateau.  Biventricular 
pacemakers, introduced  in 2002, have leveled off after their initial introduction while the 
utilization of single chamber atrial pacemakers remains low. 
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FIGURE 2:  Age of pacemaker patients at implantation over time.  The average age of 
pacemaker patients has slowly increased. 
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FIGURE 3:  Utilization of pacemakers in patients paced for sinus node dysfunction.   
The distribution of pacemaker type is similar to the group as a whole.  
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FIGURE 4:  Hospital charges associated with permanent pacemaker implantation:  
1993-2009 (in $2011):  The hospital charges associated with pacemaker implantation 
have increased over time. 
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